So, if you're low in B12, then fatigue and general weakness are going to be one of the main symptoms
Nature 399 , 7075 (1999)
W hodowlach ludzkich fibroblastw Epithalon indukowa ekspresj podjednostki katalitycznej telomerazy ( hTERT ), czemu towarzyszyo wyduenie telomerw i zwikszenie liczby podziaw komrkowych w pracy Chawinsona i wsp
FDA, where a CLL decision is anticipated in the second half of 2026
Most clinical guidance recommends: At 3 months: A1c recheck (HbA1c reflects the prior 3-month average, making this the earliest timepoint for meaningful assessment of glycemic response), metabolic panel if any GI side effects were significant At 6 months: Full panel repeat A1c, CMP, lipids, CBC to document treatment response comprehensively Annually: Full panel plus thyroid function, B12, and any additional markers relevant to your individual health picture If you experience severe or persistent gastrointestinal side effects, signs of dehydration, unusual fatigue, or any concerning symptoms, kidney function should be rechecked without waiting for a scheduled interval